TRFAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as GCAND
TRAFALGAR INTERNATIONAL, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
TRAFALGAR INTERNATIONAL, INC. revenue by segment
By business segment
By product or service
| Revenue | Q4 21 | Q3 21 | Q2 21 | Q4 20 | Q3 20 | Q2 20 | Q3 19 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $0 | $0 | $12.63K | $0 | $0 | $48.04K | – | – | – |
| Consulting Fees [Member] | – | – | – | – | – | – | $2.62K | – | – |
By region
From the segment and revenue-disaggregation notes of Trafalgar International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.